WESTBURY... N.Y.... Jan. 6... 2014 /PRNewswire/ — Vasomedical... Inc. (“Vasomedical”) (OTCBB: VASO)... a diversified medical technology company specializing in the design... manufacture and sale of medical devices including EECP® (Enhanced External Counterpulsation) Therapy systems... the gold standard of ECP therapy... announced today that the U.S. Food and Drug Administration (FDA)... Department of Health and Human Services...
Read More

WESTBURY, N.Y., Nov. 14, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today reported its operating results for the three months ended September 30, 2013. “We are pleased to report that during the third quarter of 2013 the Company recorded significant growth in both the Equipment segment and the Sales Representation segment.  Total equipment sales...
Read More

WESTBURY, N.Y., Nov. 13, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology, including EECP® Therapy systems, the gold standard of ECP therapy, today announced it has been named to the Deloitte’s Technology Fast 500™ for the second consecutive...
Read More

WESTBURY, N.Y., Sept. 9, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTCBB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP® (Enhanced External Counterpulsation) Therapy systems, the gold standard of ECP therapy, announced today that its EECP Therapy has been given a lla Class of Recommendation...
Read More

WESTBURY, N.Y., Aug. 13, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today reported its operating results for the three months ended June 30, 2013. “We are pleased by the continued growth reported for the second quarter of 2013, mostly attributable to the increased activity in our sales representation business in the U.S. and our...
Read More